Successful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy

about

Successful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy

Item

http://www.wikidata.org/entity/Q58791929

description

scientific article published on 09 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@en

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@nl

type

Item

label

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@en

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@nl

prefLabel

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@en

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@nl

P1476

Successful Treatment of Diabet ...... uous Renal Replacement Therapy

@en

P2093

Dandan Zhang

http://www.w3.org/2001/XMLSchema#string

Fengyun Wang

http://www.w3.org/2001/XMLSchema#string

Haiying Wu

http://www.w3.org/2001/XMLSchema#string

Hui Sun

http://www.w3.org/2001/XMLSchema#string

Linqi Chen

http://www.w3.org/2001/XMLSchema#string

Rongrong Xie

http://www.w3.org/2001/XMLSchema#string

Shuiyan Wu

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Wang

http://www.w3.org/2001/XMLSchema#string

Xiuli Chen

http://www.w3.org/2001/XMLSchema#string

Ying Li

http://www.w3.org/2001/XMLSchema#string

P2860

Rare complications of pediatric diabetic ketoacidosis.

Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.

Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?

Continuous renal replacement therapy-the new treatment of seriously hyperglycemia.

Refractory DKA as first presentation of acromegaly and a potential role for continuous venovenous hemofiltration in its successful management.

High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial.

Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis.

Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction.

P2888

s13300-018-0484-3

P304

2179-2184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S13300-018-0484-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ting Chen

P577

2018-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30094785

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia

P932

6167281

http://www.w3.org/2001/XMLSchema#string